Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma
- PMID: 18937267
- PMCID: PMC6296219
- DOI: 10.1002/cncr.23914
Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma
Abstract
Background: There is a lack of research on ethnic disparities in survival among patients with non-Hodgkin lymphoma (NHL), although these disparities have been documented for patients with many other tumors.
Methods: A retrospective cohort of 13,321 patients diagnosed with incident NHL at age > or = 65 years from 1992 to 1999 were identified from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database with 11 years of follow-up. Of these patients, 11,868 were Caucasians, 533 were African Americans, and 920 were other ethnicities. A time-to-event Cox regression model was used to examine the relative risk of all-cause and disease-specific mortality.
Results: A larger proportion (72.2%) of African Americans were in the poorest quartile of socioeconomic status as measured by the poverty level compared with 21.8% of Caucasians, and 43.2% of African Americans received chemotherapy compared with 52.4% of Caucasians (P < .01). Hazard ratio of all-cause and NHL-specific mortality increased significantly with age, advanced stage, higher comorbidity scores, and poorer socioeconomic status. Patients receiving either chemotherapy or radiotherapy or both were significantly less likely to die. After taking into account differences in treatment, comorbidity, and socioeconomic status, there was no statistically significant difference in the risk of all-cause (hazard ratio, 0.97; 95% confidence interval, 0.88-1.08) and disease-specific mortality (hazard ratio, 1.07; 95% confidence interval, 0.92-1.25) between African Americans and Caucasians.
Conclusions: The risk of mortality in patients with NHL was associated with socioeconomic status and was reduced in patients receiving chemotherapy. No significant differences in the risk of mortality were observed between African Americans and Caucasians after controlling for factors such as treatment and socioeconomic status.
(c) 2008 American Cancer Society
Similar articles
-
Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer.Cancer. 2007 Aug 1;110(3):660-9. doi: 10.1002/cncr.22826. Cancer. 2007. PMID: 17582625
-
Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer.Am J Clin Oncol. 2008 Apr;31(2):125-32. doi: 10.1097/COC.0b013e3181587890. Am J Clin Oncol. 2008. PMID: 18391595
-
Survival Differences by Race/Ethnicity and Neighborhood Socioeconomic Status in Adolescents and Young Adults Diagnosed with Non-Hodgkin Lymphoma.J Adolesc Young Adult Oncol. 2015 Jun;4(2):76-83. doi: 10.1089/jayao.2014.0037. J Adolesc Young Adult Oncol. 2015. PMID: 26812555
-
Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma.Am J Clin Oncol. 2007 Apr;30(2):163-71. doi: 10.1097/01.coc.0000251356.63237.4f. Am J Clin Oncol. 2007. PMID: 17414466
-
African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review.Cancer Biomark. 2007;3(6):301-13. doi: 10.3233/cbm-2007-3604. Cancer Biomark. 2007. PMID: 18048968 Free PMC article. Review.
Cited by
-
Socioeconomic Status and Overall Survival Among Patients With Hematological Malignant Neoplasms.JAMA Netw Open. 2024 Mar 4;7(3):e241112. doi: 10.1001/jamanetworkopen.2024.1112. JAMA Netw Open. 2024. PMID: 38436954 Free PMC article.
-
A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma.J Oncol. 2022 Oct 27;2022:9636790. doi: 10.1155/2022/9636790. eCollection 2022. J Oncol. 2022. PMID: 36339648 Free PMC article.
-
Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method.Front Oncol. 2022 Sep 27;12:942122. doi: 10.3389/fonc.2022.942122. eCollection 2022. Front Oncol. 2022. PMID: 36237337 Free PMC article.
-
Socioeconomic inequalities in treatment and relative survival among patients with diffuse large B-cell lymphoma: a Hong Kong population-based study.Sci Rep. 2021 Sep 9;11(1):17950. doi: 10.1038/s41598-021-97455-5. Sci Rep. 2021. PMID: 34504223 Free PMC article.
-
Prognostic Factors, Survival Analyses and the Risk of Second Primary Cancer: A Population-Based Study on Burkitt Lymphoma/Leukemia.Diseases. 2021 Jun 15;9(2):43. doi: 10.3390/diseases9020043. Diseases. 2021. PMID: 34203748 Free PMC article.
References
-
- National Cancer Institute. Cancer Stat Fact Sheets http://seer.cancer.gov/statfacts/html/nhl.html. (Accessed February 11, 2008).
-
- American Cancer Society. Cancer Facts & Figures 2007. http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf. (Accessed February 11, 2008).
-
- Zheng T, Mayne ST, Boyle P, et al. Epidemiology of non-Hodgkin lymphoma in Connecticut, 1935–1988. Cancer 1992;70:840–849. - PubMed
-
- Groves FD, Linet MS, Travis LB, et al. Cancer surveillance series: non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000;92:1240–1251. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
